Target type: biologicalprocess
The chemical reactions and pathways involving cysteine, 2-amino-3-mercaptopropanoic acid. [GOC:go_curators]
Cysteine metabolism is a fundamental biological process essential for various cellular functions. It involves a series of enzymatic reactions that regulate the synthesis, breakdown, and utilization of cysteine, a sulfur-containing amino acid.
Cysteine is a crucial component of proteins, acting as a building block for their structure and function. It is also involved in redox reactions, contributing to the maintenance of cellular redox homeostasis. Additionally, cysteine serves as a precursor for the biosynthesis of glutathione, a vital antioxidant.
**Synthesis:**
Cysteine can be synthesized de novo in the body from methionine via the transsulfuration pathway. This pathway involves several enzymes, including cystathionine β-synthase and cystathionine γ-lyase.
**Breakdown:**
The degradation of cysteine begins with its conversion to pyruvate and sulfate. This process is catalyzed by cysteine dioxygenase, which initiates the formation of cysteine sulfinate. Subsequent reactions lead to the production of sulfate and pyruvate.
**Utilization:**
Cysteine is utilized in various metabolic processes, including:
* **Protein synthesis:** As a building block for proteins, cysteine contributes to their structure and function.
* **Redox reactions:** Cysteine's sulfhydryl group participates in redox reactions, essential for maintaining cellular redox balance.
* **Glutathione synthesis:** Cysteine serves as a precursor for the synthesis of glutathione, a critical antioxidant molecule.
* **Other metabolic pathways:** Cysteine is involved in various metabolic pathways, including the biosynthesis of taurine, coenzyme A, and other sulfur-containing compounds.
**Regulation:**
Cysteine metabolism is tightly regulated by factors such as:
* **Nutritional intake:** Dietary cysteine intake influences the levels of cysteine in the body.
* **Hormonal signals:** Hormones like insulin and growth hormone can regulate cysteine metabolism.
* **Cellular demand:** Cellular demand for cysteine influences its synthesis and degradation.
**Disorders:**
Dysregulation of cysteine metabolism can lead to various disorders, including:
* **Cystinuria:** A genetic disorder characterized by the accumulation of cystine in the kidneys, leading to kidney stones.
* **Homocystinuria:** A metabolic disorder resulting from a deficiency in cystathionine β-synthase, leading to high levels of homocysteine in the blood.
* **Other disorders:** Cysteine metabolism is also linked to other disorders, such as neurodegenerative diseases, cardiovascular diseases, and cancer.
In summary, cysteine metabolism is a complex and essential process involved in various cellular functions. Understanding its regulation and potential dysregulation is crucial for maintaining health and preventing related disorders.'
"
Protein | Definition | Taxonomy |
---|---|---|
Cystathionine gamma-lyase | A cystathionine gamma-lyase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P32929] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
aminooxyacetic acid | (aminooxy)acetic acid : A member of the class of hydroxylamines that is acetic acid substituted at postion 2 by an aminooxy group. It is a compound which inhibits aminobutyrate aminotransferase activity in vivo, resulting in increased levels of gamma-aminobutyric acid in tissues. Aminooxyacetic Acid: A compound that inhibits aminobutyrate aminotransferase activity in vivo, thereby raising the level of gamma-aminobutyric acid in tissues. | amino acid; hydroxylamines; monocarboxylic acid | anticonvulsant; EC 2.6.1.19 (4-aminobutyrate--2-oxoglutarate transaminase) inhibitor; EC 4.2.1.22 (cystathionine beta-synthase) inhibitor; nootropic agent |
salicylic acid | Scalp: The outer covering of the calvaria. It is composed of several layers: SKIN; subcutaneous connective tissue; the occipitofrontal muscle which includes the tendinous galea aponeurotica; loose connective tissue; and the pericranium (the PERIOSTEUM of the SKULL). | monohydroxybenzoic acid | algal metabolite; antifungal agent; antiinfective agent; EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor; keratolytic drug; plant hormone; plant metabolite |
aurintricarboxylic acid | aurintricarboxylic acid : A member of the class of quinomethanes that is 3-methylidene-6-oxocyclohexa-1,4-diene-1-carboxylic acid in which the methylidene hydrogens are replaced by 4-carboxy-3-hydroxyphenyl groups. The trisodium salt is the biological stain 'chrome violet CG' while the triammonium salt is 'aluminon'. Aurintricarboxylic Acid: A dye which inhibits protein biosynthesis at the initial stages. The ammonium salt (aluminon) is a reagent for the colorimetric estimation of aluminum in water, foods, and tissues. | monohydroxybenzoic acid; quinomethanes; tricarboxylic acid | fluorochrome; histological dye; insulin-like growth factor receptor 1 antagonist |
mesalamine | mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position. Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed) | amino acid; aromatic amine; monocarboxylic acid; monohydroxybenzoic acid; phenols | non-steroidal anti-inflammatory drug |
penicillamine | penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group. Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease. | non-proteinogenic alpha-amino acid; penicillamine | antirheumatic drug; chelator; copper chelator; drug allergen |
nitroxoline | nitroxoline : A monohydroxyquinoline in which the hydroxy group is positioned at C-8 with a nitro group trans to it at C-5. nitroxoline: structure in Merck Index, 9th ed, #6475; RN given refers to parent cpd | C-nitro compound; monohydroxyquinoline | antifungal agent; antiinfective agent; antimicrobial agent; renal agent |
olsalazine | olsalazine : An azobenzene that consists of two molecules of 4-aminosalicylic acid joined by an azo linkage. A prodrug for mesalazine, an anti-inflammatory drug, it is used (as the disodium salt) in the treatment of inflammatory bowel disease. olsalazine: cpd with 2 salicylate molecules linked together by an azo bond | azobenzenes; dicarboxylic acid | non-steroidal anti-inflammatory drug; prodrug |
methyldopa | alpha-methyl-L-dopa : A derivative of L-tyrosine having a methyl group at the alpha-position and an additional hydroxy group at the 3-position on the phenyl ring. Methyldopa: An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent. | L-tyrosine derivative; non-proteinogenic L-alpha-amino acid | alpha-adrenergic agonist; antihypertensive agent; hapten; peripheral nervous system drug; sympatholytic agent |
6-amino-7-chloro-5,8-dioxoquinoline | 6-amino-7-chloro-5,8-dioxoquinoline: quinone structure important in this cpd; structure | ||
kalafungin | kalafungin: nanaomycin D from Streptomyces rosa & is enantiomer of kalafungin; RN given refers to (3aR-(3aalpha,5alpha,11balpha))-isomer; see also nanaomycin C; structure of kalafungin in first source; structure of nanaomycin in second source | ||
nsc228155 | |||
agathisflavone | agathisflavone : A biflavonoid that is obtained by oxidative coupling of two molecules of apigenin resulting in a bond between positions C-6 and C-8 of the two chromene rings. agathisflavone: bis-apigenin coupled at 6 and 8 positions; isolated from the plant Canarium manii; has hepatoprotective activity against carbon tetrachloride-induced hepatotoxicity | biaryl; biflavonoid; hydroxyflavone | antineoplastic agent; antiviral agent; hepatoprotective agent; metabolite |
cupressuflavone | cupressuflavone : A biflavonoid that is obtained by oxidative coupling of two molecules of apigenin resulting in a bond between positions C-8 of the two chromene rings respectively. Isolated from Cupressus sempervirens and Juniperus occidentalis, it exhibits free radical scavenging and antielastase activities. cupressuflavone: from Cupressus macrocarpa; structure in first source | biflavonoid; hydroxyflavone; ring assembly | EC 3.4.21.37 (leukocyte elastase) inhibitor; metabolite; radical scavenger |
podocarpusflavone a | podocarpusflavone A: isolated from Podocarpus imbricatus | flavonoid oligomer | |
aminoethoxyvinylglycine | aminoethoxyvinylglycine: RN given for (S-(E))-isomer |